Researchers conducted a study of 65 children younger than 22 years with COVID-19 at Steven and Alexandra Cohen Children’s Medical Center at New Hyde Park, N.Y.-based Northwell Health. Cases were identified from patients with fever and/or respiratory symptoms who underwent a nucleic acid amplification-based COVID-19 test.
Seven study takeaways:
1. About half of all children with COVID-19 were chronically ill or immunocompromised.
2. Elevated white blood cell count and C-reactive protein levels were associated with greater illness severity.
3. Overall, 86 percent of patients had a fever, 60 percent had lower respiratory symptoms or signs, and 62 percent had gastrointestinal symptoms.
4. Thirty-five percent of patients required intensive care and 34 percent required respiratory support.
5. Virus severity was lowest in infants younger than 60 days.
6. Among children hospitalized for COVID-19, most were younger than 60 days or older than 12 years of age.
7. One death was reported.
More articles on public health:
Cases rise in 25 states; kids make up 10% of all cases — 7 COVID-19 updates
Healthy 19-year-old dies from apparent COVID-19 neurological complications
24 states where COVID-19 is spreading fastest, slowest: Oct. 1
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
